BioPharm International A major unsolved challenge in adjuvant development is how to achieve a potent adjuvant effect while avoiding reactogenicity or toxicity Aug 2, 2007 By: Nikolai Petrovsky, Susanne Heinzel, Yoshikazu Honda, A. Bruce Lyons BioPharm International ABSTRACT Older vaccines made from live or killed whole organisms were effective, but suffered from high reactogenicity. As vaccine manufacturers developed […]
Counseling helps patients start and complete HPV shot regimen
American Medical News Only 30% who begin the three-dose vaccine series actuallycomplete it, a new study says. By Christine S. Moyer, amednews staff. Posted Nov. 23, 2010. Educating female patients age 9 to 26 about the human papillomavirus vaccine could help bolster their protection against cervical cancer, the author of a new report says. Only […]
Is Your Friendly Neighborhood Blogger Pushing Drugs?
CBS Moneywatch.com By Marlys Harris | Nov 22, 2010 Could the blogger next door be accepting dough from big companies to shill their products? According to Kara McGuire, a staffer with the Minneapolis StarTribune, the answer is literally ‘yes.” Her recent story, “A New Recipe for the Web”, described General Mills’ efforts to promote its cake mixes […]
Facts About Human Papillomavirus
Women Cancer Health Treatment HPV might not a popular acronym compared to HIV, but Human Papillomavirus can bring as much threat as the latter. Some of us have heard about it from TV commercials dealing with cervical cancer awareness, others get some tidbits at school or magazine articles. But, except for doctors or health care […]
Nobel Laureate, Dr. Harald zur Hausen, on HPV and ‘cancer’ vaccines
Many media sources claim anyone questioning vaccines is either ignorant and/or paying attention only to ‘junk’ science. Perhaps some of these ‘sources’ will listen to the man who won the Nobel Prize in Medicine for the discovery of HPV. FOR IMMEDIATE RELEASE PRLog (Press Release) – Nov 06, 2010– In 2008, half of the […]